Your Article Summary
See Latest ArticlesSanofi-aventis and Kyowa Hakko Kirin enter into a Collaboration and Licensing Agreement on an Anti LIGHT fully human monoclonal antibody
Sanofi-aventis, 05/15/09
Sanofi-aventis and Kyowa Hakko Kirin Co., Ltd. announced that they have signed a collaboration and licensing agreement under which sanofi-aventis receives worldwide rights to Kyowa Hakko Kirin's anti-LIGHT fully human monoclonal antibody.
Today in Licensure/Accreditation...keeping you current
Receive free subspecialty "5-minute updates" via email
New ncqa disease management standards focus on measurement, quality improvement and transparency
National Committee for Quality Assurance (NCQA), 12/15/09
EDI Accrediting Firm Updates Criteria
HealthDataManagement, 12/09/09
Consumer Demand for H1N1 Information Highlights Importance of Accreditation for Health Call Centers
URAC News Releases, 12/07/09